ArticleJournal of diabetes science and technology2021

Analysis of a Unique Postmarket Surveillance Dataset That a Glucose Test-Strip Demonstrates no Evidence of Interference and Robust Clinical Accuracy Irrespective of the Prescription Medication Status of a Large Cohort of Patients With Diabetes.

Mike Grady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.